Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
BeiGene Ltd | 49B | Jun 13, 2024 | 11.50 | +5.50 |
Biomed-Lubin Wytwornia Surowic I Szczepionek S.A. | 6NQ | Jun 13, 2024 | 1.06 | -0.38 |
Biophytis | 6XB | Jun 13, 2024 | 0.00 | 0.00 |
Biotest AG | BIO3 | Jun 13, 2024 | 25.70 | +0.39 |
Bioton S.A. | 7U5 | Jun 13, 2024 | 0.79 | +0.89 |
Bioventix Plc | 51B | Jun 13, 2024 | 47.80 | +3.91 |
Bone Therapeutics S.A. | BT1 | Jun 13, 2024 | 0.01 | 0.00 |
Cellectis | ZVA | Jun 13, 2024 | 2.19 | -2.24 |
Celon Pharma SA | 8RP | Jun 13, 2024 | 3.40 | +0.44 |
Chromadex Corp | OCD1 | Jun 13, 2024 | 2.76 | -2.82 |
Circassia Group Plc | 82C | Jun 13, 2024 | 0.78 | +0.65 |
CKLIFE SCIENCES | LSI | Jun 13, 2024 | 0.04 | -2.78 |
Clinuvel Pharmaceuticals Ltd | UR9A | Jun 13, 2024 | 8.80 | +2.33 |
Clinuvel Pharmaceuticals Ltd Ordinary Shares (Australia) | UR9 | Jun 13, 2024 | 8.89 | +0.85 |
Csl Ltd SPONSORED ADR (Australia) | CSJA | Jun 13, 2024 | 87.00 | +1.16 |
CSL Ltd. | CSJ | Jun 13, 2024 | 176.94 | +0.53 |
CSTONE PHARMAC. DL-,0001 | PH4 | Jun 13, 2024 | 0.12 | -2.36 |
CYNATA THERAPEUTICS LTD Ordinary Shares(Australia) | 51S | Jun 13, 2024 | 0.18 | 0.00 |
D.Western Therapeutics Institute, Inc. | 6DW | Jun 13, 2024 | 0.44 | +0.46 |
Diaceutics Plc | 7DC | Jun 13, 2024 | 1.44 | -1.37 |
Everest Medicines Limited | 6HN | Jun 13, 2024 | 2.26 | -0.88 |
Evgen Pharma Plc | 8EV | Jun 13, 2024 | 0.00 | 0.00 |
Futura Medical | GYX | Jun 13, 2024 | 0.41 | -0.49 |
Galapagos NV - American Depositary Shares | GXEA | Jun 13, 2024 | 24.20 | -0.82 |
GeNeuro SA | GEM | Jun 13, 2024 | 2.09 | +10.00 |
Genoway | JEH | Jun 13, 2024 | 4.16 | 0.00 |
Genscript Biotech Corporation | G51 | Jun 13, 2024 | 1.10 | -0.90 |
GNI Group Ltd. | 3G6 | Jun 13, 2024 | 12.90 | -1.53 |
Healios K.K. | 6VX | Jun 13, 2024 | 0.96 | +0.52 |
Hemogenyx Pharmaceuticals Plc | 5HU | Jun 13, 2024 | 0.01 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.